Microfluidics and Nanotechnology for Detection of Global Infectious Diseases

Gregory L. Damhorst, Maurine Murtagh, William R. Rodriguez, Rashid Bashir

Research output: Contribution to journalReview article

Abstract

Infectious diseases remain among the world's leading causes of mortality and years of life lost. Significant attention has been paid to the "Big Three" infectious pathogens - human immunodeficiency virus (HIV), malaria, and tuberculosis (TB) - but other conditions such as Chagas' disease, dengue, Ebola, and typhoid, as well as multipathogen processes such as viral hepatitis, pneumonia, and diarrhea, also have major global impact. Addressing these significant disease burdens, which disproportionately impact the world's poorest regions, is a multifaceted grand challenge, requiring new solutions and new technologies. Diagnostics enabled by advances in microfluidics and nanotechnologies can be an important part of the solution. Advantages such as smaller sample size, increased sensitivity, and new multiplexed sensing modalities in a point-of-care format can allow rapid dissemination of test results in remote and resource-limited regions. In this review, we provide a critical assessment of the state-of-the-art in use of these technologies for detection of HIV, malaria, and TB. In addition to discussing opportunities and future prospects, we also discuss the need for additional governmental and nongovernmental funding sources to develop these technologies to their fullest potential, and the need for new business models to enable their commercialization and deployment.

Original languageEnglish (US)
Article number7067024
Pages (from-to)150-160
Number of pages11
JournalProceedings of the IEEE
Volume103
Issue number2
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Fingerprint

Nanotechnology
Microfluidics
Viruses
Pathogens
Industry

Keywords

  • Biosensors
  • HIV/AIDS
  • diagnostics
  • global health
  • infectious diseases
  • malaria
  • microfluidics
  • nanotechnology
  • point-of-care
  • tuberculosis

ASJC Scopus subject areas

  • Electrical and Electronic Engineering

Cite this

Microfluidics and Nanotechnology for Detection of Global Infectious Diseases. / Damhorst, Gregory L.; Murtagh, Maurine; Rodriguez, William R.; Bashir, Rashid.

In: Proceedings of the IEEE, Vol. 103, No. 2, 7067024, 01.02.2015, p. 150-160.

Research output: Contribution to journalReview article

Damhorst, Gregory L. ; Murtagh, Maurine ; Rodriguez, William R. ; Bashir, Rashid. / Microfluidics and Nanotechnology for Detection of Global Infectious Diseases. In: Proceedings of the IEEE. 2015 ; Vol. 103, No. 2. pp. 150-160.
@article{add9fd0450584fcc85ef9064e3ed534f,
title = "Microfluidics and Nanotechnology for Detection of Global Infectious Diseases",
abstract = "Infectious diseases remain among the world's leading causes of mortality and years of life lost. Significant attention has been paid to the {"}Big Three{"} infectious pathogens - human immunodeficiency virus (HIV), malaria, and tuberculosis (TB) - but other conditions such as Chagas' disease, dengue, Ebola, and typhoid, as well as multipathogen processes such as viral hepatitis, pneumonia, and diarrhea, also have major global impact. Addressing these significant disease burdens, which disproportionately impact the world's poorest regions, is a multifaceted grand challenge, requiring new solutions and new technologies. Diagnostics enabled by advances in microfluidics and nanotechnologies can be an important part of the solution. Advantages such as smaller sample size, increased sensitivity, and new multiplexed sensing modalities in a point-of-care format can allow rapid dissemination of test results in remote and resource-limited regions. In this review, we provide a critical assessment of the state-of-the-art in use of these technologies for detection of HIV, malaria, and TB. In addition to discussing opportunities and future prospects, we also discuss the need for additional governmental and nongovernmental funding sources to develop these technologies to their fullest potential, and the need for new business models to enable their commercialization and deployment.",
keywords = "Biosensors, HIV/AIDS, diagnostics, global health, infectious diseases, malaria, microfluidics, nanotechnology, point-of-care, tuberculosis",
author = "Damhorst, {Gregory L.} and Maurine Murtagh and Rodriguez, {William R.} and Rashid Bashir",
year = "2015",
month = "2",
day = "1",
doi = "10.1109/JPROC.2014.2385078",
language = "English (US)",
volume = "103",
pages = "150--160",
journal = "Proceedings of the IEEE",
issn = "0018-9219",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
number = "2",

}

TY - JOUR

T1 - Microfluidics and Nanotechnology for Detection of Global Infectious Diseases

AU - Damhorst, Gregory L.

AU - Murtagh, Maurine

AU - Rodriguez, William R.

AU - Bashir, Rashid

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Infectious diseases remain among the world's leading causes of mortality and years of life lost. Significant attention has been paid to the "Big Three" infectious pathogens - human immunodeficiency virus (HIV), malaria, and tuberculosis (TB) - but other conditions such as Chagas' disease, dengue, Ebola, and typhoid, as well as multipathogen processes such as viral hepatitis, pneumonia, and diarrhea, also have major global impact. Addressing these significant disease burdens, which disproportionately impact the world's poorest regions, is a multifaceted grand challenge, requiring new solutions and new technologies. Diagnostics enabled by advances in microfluidics and nanotechnologies can be an important part of the solution. Advantages such as smaller sample size, increased sensitivity, and new multiplexed sensing modalities in a point-of-care format can allow rapid dissemination of test results in remote and resource-limited regions. In this review, we provide a critical assessment of the state-of-the-art in use of these technologies for detection of HIV, malaria, and TB. In addition to discussing opportunities and future prospects, we also discuss the need for additional governmental and nongovernmental funding sources to develop these technologies to their fullest potential, and the need for new business models to enable their commercialization and deployment.

AB - Infectious diseases remain among the world's leading causes of mortality and years of life lost. Significant attention has been paid to the "Big Three" infectious pathogens - human immunodeficiency virus (HIV), malaria, and tuberculosis (TB) - but other conditions such as Chagas' disease, dengue, Ebola, and typhoid, as well as multipathogen processes such as viral hepatitis, pneumonia, and diarrhea, also have major global impact. Addressing these significant disease burdens, which disproportionately impact the world's poorest regions, is a multifaceted grand challenge, requiring new solutions and new technologies. Diagnostics enabled by advances in microfluidics and nanotechnologies can be an important part of the solution. Advantages such as smaller sample size, increased sensitivity, and new multiplexed sensing modalities in a point-of-care format can allow rapid dissemination of test results in remote and resource-limited regions. In this review, we provide a critical assessment of the state-of-the-art in use of these technologies for detection of HIV, malaria, and TB. In addition to discussing opportunities and future prospects, we also discuss the need for additional governmental and nongovernmental funding sources to develop these technologies to their fullest potential, and the need for new business models to enable their commercialization and deployment.

KW - Biosensors

KW - HIV/AIDS

KW - diagnostics

KW - global health

KW - infectious diseases

KW - malaria

KW - microfluidics

KW - nanotechnology

KW - point-of-care

KW - tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84926344779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926344779&partnerID=8YFLogxK

U2 - 10.1109/JPROC.2014.2385078

DO - 10.1109/JPROC.2014.2385078

M3 - Review article

AN - SCOPUS:84926344779

VL - 103

SP - 150

EP - 160

JO - Proceedings of the IEEE

JF - Proceedings of the IEEE

SN - 0018-9219

IS - 2

M1 - 7067024

ER -